West Pharmaceutical Services Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones11-02

DJ West Pharmaceutical Services Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) rose 2.78% to $316.50 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.41% to 5,728.80 and the Dow Jones Industrial Average rising 0.69% to 42,052.19.

The stock's rise snapped a two-day losing streak.

West Pharmaceutical Services Inc. closed $97.20 short of its 52-week high ($413.70), which the company achieved on February 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Abbott Laboratories $(ABT)$ rose 4.61% to $118.60, Becton Dickinson & Co. $(BDX)$ rose 0.71% to $235.24, and Baxter International Inc. $(BAX)$ rose 0.48% to $35.87.

Trading volume (572,803) remained 5,249 below its 50-day average volume of 578,052.

Data source: Dow Jones Market Data, FactSet. Data compiled November 1, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 01, 2024 17:07 ET (21:07 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment